跳至主要内容
临床试验/EUCTR2004-000517-19-GB
EUCTR2004-000517-19-GB进行中(未招募)不适用

PRETREATMENT WITH HIGH DOSE CLOPIDOGREL FOR REDUCTION OF THROMBOTIC EVENTS AFTER ELECTIVE CORONARY TERRITORY STENTING WITH DRUG ELUTING STENTS: ThePROTECTED Study - The PROTECTED Study

Blackpool Fylde & Wyre Healthcare NHS Trust0 个研究点目标入组 100 人开始时间: 2005年10月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Consecutive patients suitable for elective coronary stenting using Drug eluting stents will be eligible and recruited for the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria will be history of bleeding diathesis, acute myocardial infarction or acute coronary syndrome/troponin elevation within 14 days, stroke within 3 months, drug or alcohol abuse, pro-thrombin time >1.5 times control, platelet count <100,000/cu.mm, hematocrit <25%, serum creatinine > 4.0mg/dl, or previous use of theinopyridines or GP IIb/IIIa inhibitors

研究者

发起方
Blackpool Fylde & Wyre Healthcare NHS Trust

相似试验

PRETREATMENT WITH HIGH DOSE CLOPIDOGREL FOR... | 临床试验